Abortion pill maker GenBioPro hires lobbying firm Emergent

  • Lobbying disclosure is a first for a Nevada-based company
  • GenBioPro in litigation over Mississippi state abortion law

(Reuters) – GenBioPro Inc has hired its first-ever federal lobbying firm as the abortion drug maker faces new legal and regulatory pressures following the U.S. Supreme Court’s ruling last month. the latter annulling the 1973 decision which recognized a constitutional right to abortion.

Nevada-based GenBioPro has hired a team from Emergent Strategies LLC in Washington, DC, led by Scott Eckart, according to a US lobbying disclosure form the company filed July 11. Eckart was previously a top Democratic lobbyist at the U.S. Chamber of Commerce.

GenBioPro lobbyists said on the form that they would generally litigate issues related to medical abortion, access to abortion services, and issues related to U.S. Food and Drug Administration approval. mifepristone, an abortifacient drug. GenBioPro sells a generic version of mifepristone, one of two drugs used in medical abortions.

Join now for FREE unlimited access to Reuters.com

Register

The lobbying comes as White House Biden pledged to oppose any efforts by states to restrict FDA-approved medical abortions following the Supreme Court’s 6-3 ruling in the Dobbs case. against Jackson Women’s Health Organization.

U.S. Attorney General Merrick Garland said June 24 that states “cannot ban mifepristone due to disagreement with the FDA’s expert judgment on its safety and efficacy.”

Eckart and a representative for GenBioPro did not immediately respond to messages seeking comment on Tuesday.

GenBioPro is also locked in a legal battle in federal court in Mississippi, where company attorneys at Latham & Watkins are challenging a state law that requires in-person visits by patients to doctors to obtain mifepristone, as well. known as RU-486.

A Mississippi attorney, Assistant Attorney General Doug Miracle, argued in court at a hearing last month that GenBioPro’s case unlawfully interfered with states’ “inherent police power” to regulate abortion.

U.S. District Judge Henry Wingate in Jackson, Mississippi, did not immediately rule.

Spending on federal abortion-related lobbying increased as Roe v. Wade, the 50-year-old ruling that found a constitutional right to abortion, was threatened by the Supreme Court, according to OpenSecrets, a nonpartisan research organization that tracks US advocacy dollars. . The outlet said in a recent report that abortion rights groups spent about $1.04 million in 2019, up from more than $1.72 million last year.

Other lobbying clients of Emergent, founded in 2018, include Instacart owner Maplebear Inc; Alliance of Online Lenders; S&P Global Inc; and Federation of American Hospitals.

Read more:

Abortion drug maker says Mississippi can’t ban pill despite Supreme Court ruling

White House prepares to fight states over abortion pill

Judge weighs abortion drug maker’s challenge to Mississippi law

America’s Next Abortion Battle Is Over Pills, and It Has Already Begun

Join now for FREE unlimited access to Reuters.com

Register

Our standards: The Thomson Reuters Trust Principles.

About Michael Murphy

Check Also

Indiana passes restrictive abortion law, causing economic fallout

Comment this story Comment Indiana’s sweeping new abortion ban produced immediate political and economic fallout …